Product profile
Glempa
Empagliflozin
Product overview
Regulatory-friendly overview of dosage forms and commercial presentations.
This page summarizes the current product entry from the supplied catalogue source.
Active ingredient
Empagliflozin
Therapeutic area
Hypoglycemics
Available dosage forms
Tablet
Available strengths
10mg; 25mg
Pack sizes
14’s
Presentations
1
Regulatory note
This catalogue is informational only. Pricing, promotional claims, and market-specific availability are not shown.
Catalogue access
Need the complete portfolio? Download the source file used for this catalogue.
Commercial presentations
Glempa
Available strengths and pack sizes are listed below exactly as provided in the source file.
| Therapeutic area | Generic | Dosage form | Strength | Pack size |
|---|---|---|---|---|
| Hypoglycemics | Empagliflozin | Tablet | 10mg; 25mg | 14’s |